Bioplatforms Australia
  • Platforms
    • Genomics
    • Proteomics
    • Metabolomics
    • Synthetic Biology
    • Multiomics Network
    • Bioinformatics
  • Missions
    • Agriculture & Food
    • Biodiversity & Environment
    • Human Health
  • Initiatives
  • Partnerships
  • Translation
  • About
    • About Us
    • NCRIS
    • Board
    • Team Contacts
    • News
  • Data Portal
Select Page
Major breakthrough in type 1 diabetes: PromarkerD predicts kidney disease

Major breakthrough in type 1 diabetes: PromarkerD predicts kidney disease

by Aude Touffu | Sep 10, 2024 | Human Health

Proteomics International Laboratories has released a groundbreaking study showing that its PromarkerD predictive test can effectively forecast renal decline in patients with type 1 diabetes. This exciting development, presented at the recent Australasian Diabetes...
Parliamentary Friends of Science event highlights Australia’s synthetic biology future

Parliamentary Friends of Science event highlights Australia’s synthetic biology future

by Aude Touffu | Aug 27, 2024 | Agriculture and Food

At a recent Parliamentary Friends of Science event in Canberra, synthetic biology took centre stage as a transformative force ready to reshape industries and tackle global challenges. Held at Parliament House, this gathering attracted scientists, policymakers, and...
Genomic research and Indigenous knowledge collaborate to protect the greater bilby

Genomic research and Indigenous knowledge collaborate to protect the greater bilby

by Aude Touffu | Aug 20, 2024 | Biodiversity and Environment

A new study published in Nature Ecology & Evolution has combined genomic research and Indigenous knowledge to enhance conservation efforts for the greater bilby, also known as Ninu (Macrotis lagotis), a culturally and ecologically significant marsupial...
Pioneering Australian vaccine innovation in the wake of Covid-19

Pioneering Australian vaccine innovation in the wake of Covid-19

by Aude Touffu | Aug 19, 2024 | Human Health

The emergence of COVID-19 and the ensuing pandemic have demonstrated the ongoing threat that infectious diseases pose to our health, economy, and lifestyle. While traditional vaccines often take years to develop, the urgency of the pandemic has redefined expectations,...
Drug Target Identification node establishment at the Monash Proteomics and Metabolomics Platform

Drug Target Identification node establishment at the Monash Proteomics and Metabolomics Platform

by Aude Touffu | Aug 18, 2024 | Human Health

To bring new therapeutics into clinical use, understanding their mechanisms of action is essential. However, many drug candidates identified through phenotypic screening do not have known targets. To overcome this challenge, the Australian drug discovery landscape...
Page 2 of 13«12345...10...»Last »

GET IN TOUCH

PHONE

P: +61 410 538 648
F: +61 2 9850 6200

 

CONTACT US

See team details here.

 

ABN

40 125 905 599

ADDRESS

Level 4, Building 4WW, Research Park Drive
Macquarie University, NSW 2019, Australia

  • Follow
  • Follow

Bioplatforms Australia is made possible through investment funding provided by the Commonwealth Government National Collaborative Research Infrastructure Strategy (NCRIS).